Omada Health director granted 1,435 RSUs

HILLEMAN JERYL L reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HILLEMAN JERYL L reported acquisition or exercise transactions in this Form 4 filing.

Omada Health, Inc. director Jeryl L. Hilleman received a grant of 1,435 restricted stock units of Common Stock on July 5, 2026 under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share, increasing her directly held beneficial ownership to 26,655 shares. This Form 4/A amends an earlier report that had understated both the RSU grant and resulting holdings due to an administrative error.

Insider Trade Summary

Grant/Award: 1,435 shares

Grant/Award 1 txn

Insider HILLEMAN JERYL L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	1,435	$0.00	$0.00

Holdings After Transaction: Common Stock — 26,655 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.
2. F2. This Form 4/A is being filed solely to correct the number of RSUs reported as granted on July 5, 2026, and the total number of shares beneficially owned by the Reporting Person. Due to an administrative error, the original Form 4 filing understated the number of RSUs that were granted pursuant to the Program. This amendment corrects the error to reflect the actual number of RSUs granted and the shares beneficially owned by the Reporting Person following the grant.

Key Figures

RSUs granted: 1,435 shares Shares beneficially owned after grant: 26,655 shares Reported transaction price per share: $0.0000 per share

3 metrics

RSUs granted 1,435 shares Restricted stock units granted on 2026-07-05 under the Non-Employee Director Compensation Program

Shares beneficially owned after grant 26,655 shares Director’s direct beneficial ownership following the July 5, 2026 RSU grant

Reported transaction price per share $0.0000 per share Per-share price reported for the Common Stock underlying the RSU grant

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, beneficially owned, retainer fees

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program")"

beneficially owned financial

"correct the number of RSUs reported as granted ... and the total number of shares beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

retainer fees financial

"RSUs that were granted pursuant to the Program in lieu of retainer fees"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omada Health (OMDA) disclose in Jeryl Hilleman’s latest Form 4/A?

Omada Health reported that director Jeryl L. Hilleman received a grant of 1,435 RSUs on July 5, 2026 and now directly beneficially owns 26,655 shares of Common Stock. The amendment corrects an earlier filing that understated the grant and resulting holdings.

How many RSUs did Omada Health (OMDA) grant to director Jeryl Hilleman on July 5, 2026?

Omada Health granted director Jeryl L. Hilleman 1,435 restricted stock units (RSUs) on July 5, 2026. The RSUs were issued under the Non-Employee Director Compensation Program in lieu of cash retainer fees, with each RSU representing one share of Common Stock upon settlement.

What is Jeryl Hilleman’s total beneficial ownership in Omada Health (OMDA) after this RSU grant?

Following the corrected RSU grant, Jeryl L. Hilleman beneficially owns 26,655 shares of Omada Health Common Stock. This total reflects the updated number of RSUs granted on July 5, 2026 and her direct holdings after the compensation award reported in the Form 4/A amendment.

What does each RSU granted by Omada Health (OMDA) to Jeryl Hilleman represent?

Each RSU granted to Jeryl L. Hilleman represents the right to receive one share of Omada Health Common Stock. Settlement will occur either on a date she selects under the Non-Employee Director Compensation Program or as otherwise provided by that program’s terms.

Why did Omada Health (OMDA) file this Form 4/A amendment for Jeryl Hilleman?

The Form 4/A was filed because the original report understated the number of RSUs granted and the resulting shares beneficially owned. The amendment corrects this administrative error, updating the grant to 1,435 RSUs and post-transaction ownership to 26,655 shares.

Was Jeryl Hilleman’s Omada Health (OMDA) RSU grant part of a director compensation program?

Yes. The 1,435 RSUs reported for Jeryl L. Hilleman were granted under Omada Health’s Non-Employee Director Compensation Program. They were issued in lieu of retainer fees, aligning director compensation partly with equity through restricted stock units instead of purely cash payments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/20/2026 - 07:17 PM Accepted by SEC EDGAR 07/20/2026 - 07:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HILLEMAN JERYL L

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/07/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/05/2026		A		1,435(1)(2)	A	$0	26,655(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

2. This Form 4/A is being filed solely to correct the number of RSUs reported as granted on July 5, 2026, and the total number of shares beneficially owned by the Reporting Person. Due to an administrative error, the original Form 4 filing understated the number of RSUs that were granted pursuant to the Program. This amendment corrects the error to reflect the actual number of RSUs granted and the shares beneficially owned by the Reporting Person following the grant.

	/s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)